Laura Reilly
Neurology · Overland Park, KSNPI 1821023896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 384 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,672 and has fallen 99.0% since, to $17 in 2022.
Across 384 payments — averaging $12.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$689
- AbbVie$648
- Upsher-smith Laboratories LLC$492
- Amgen$430
- Lilly USA, LLC$420
- UCB, Inc.$331
- plus $2K from 22 others
What the payments were for
- Travel & lodging$40%
- Food & beverage$4,794100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 66 | $689 |
| AbbVie(2 entities) | 59 | $648 |
| Upsher-smith Laboratories LLC | 33 | $492 |
| Amgen | 28 | $430 |
| Lilly USA, LLC | 31 | $420 |
| UCB, Inc. | 22 | $331 |
| AstraZeneca | 23 | $312 |
| Zyla Life Sciences, Inc. | 30 | $299 |
| Novartis | 14 | $191 |
| Acadia Pharmaceuticals Inc | 12 | $180 |
| Biohaven Pharmaceuticals, Inc. | 23 | $147 |
| Supernus Pharmaceuticals, Inc. | 10 | $145 |
| CSL Behring | 5 | $87 |
| Adamas Pharmaceuticals, Inc. | 4 | $73 |
| Grifols USA, LLC | 4 | $63 |
| SK Life Science, Inc. | 3 | $61 |
| Kyowa Kirin, Inc. | 3 | $42 |
| Lundbeck LLC | 3 | $37 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Boehringer Ingelheim | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| GRT US Holding, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $13 |
| Biogen | 1 | $11 |
| Novo Nordisk | 1 | $11 |
| Sunovion Pharmaceuticals Inc. | 1 | $8 |
How this compares
$4,798 in reported general payments places this provider in the 75th percentile of 131 neurology providers in Kansas.
Other neurology in Overland Park
- Stacy YoungerOverland Park$22K
- David ClarkOverland Park$22K
- John SeeleyOverland Park$11K
- Phaedra DowellOverland Park$3K
- Ivan OsorioKansas City$101.7M
- Jeffrey KaplanLenexa$1.9M
- Rajesh PahwaKansas City$889K
- Sheetal MalikTopeka$137K
- Richard DubinskyKansas City$122K
- Barbara Jean OttleyHays$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.